Ad is loading...
MRSN
Price
$2.22
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
97 days until earnings call
VRDN
Price
$19.79
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
97 days until earnings call
Ad is loading...

MRSN vs VRDN

Header iconMRSN vs VRDN Comparison
Open Charts MRSN vs VRDNBanner chart's image
Mersana Therapeutics
Price$2.22
Change-$0.00 (-0.00%)
Volume$671.92K
CapitalizationN/A
Viridian Therapeutics
Price$19.79
Change-$0.00 (-0.00%)
Volume$1.03M
CapitalizationN/A
MRSN vs VRDN Comparison Chart
Loading...
MRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MRSN vs. VRDN commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a Hold and VRDN is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (MRSN: $2.22 vs. VRDN: $19.79)
Brand notoriety: MRSN and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 65% vs. VRDN: 89%
Market capitalization -- MRSN: $274.24M vs. VRDN: $1.57B
MRSN [@Biotechnology] is valued at $274.24M. VRDN’s [@Biotechnology] market capitalization is $1.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $458.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, VRDN is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 3 bullish TA indicator(s).

  • MRSN’s TA Score: 3 bullish, 5 bearish.
  • VRDN’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, MRSN is a better buy in the short-term than VRDN.

Price Growth

MRSN (@Biotechnology) experienced а -15.59% price change this week, while VRDN (@Biotechnology) price change was -11.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.72%. For the same industry, the average monthly price growth was -7.79%, and the average quarterly price growth was +1.74%.

Reported Earning Dates

MRSN is expected to report earnings on Feb 26, 2025.

VRDN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-3.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.55B) has a higher market cap than MRSN($245M). MRSN YTD gains are higher at: -4.310 vs. VRDN (-9.137). MRSN has higher annual earnings (EBITDA): -68.51M vs. VRDN (-253.41M). VRDN has more cash in the bank: 753M vs. MRSN (155M). VRDN has less debt than MRSN: VRDN (21.1M) vs MRSN (31.5M). MRSN has higher revenues than VRDN: MRSN (34.8M) vs VRDN (302K).
MRSNVRDNMRSN / VRDN
Capitalization245M1.55B16%
EBITDA-68.51M-253.41M27%
Gain YTD-4.310-9.13747%
P/E RatioN/AN/A-
Revenue34.8M302K11,523%
Total Cash155M753M21%
Total Debt31.5M21.1M149%
FUNDAMENTALS RATINGS
MRSN vs VRDN: Fundamental Ratings
MRSN
VRDN
OUTLOOK RATING
1..100
854
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
9664
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4043
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRDN's Valuation (92) in the Biotechnology industry is in the same range as MRSN (97). This means that VRDN’s stock grew similarly to MRSN’s over the last 12 months.

VRDN's Profit vs Risk Rating (64) in the Biotechnology industry is in the same range as MRSN (96). This means that VRDN’s stock grew similarly to MRSN’s over the last 12 months.

VRDN's SMR Rating (98) in the Biotechnology industry is in the same range as MRSN (100). This means that VRDN’s stock grew similarly to MRSN’s over the last 12 months.

MRSN's Price Growth Rating (40) in the Biotechnology industry is in the same range as VRDN (43). This means that MRSN’s stock grew similarly to VRDN’s over the last 12 months.

MRSN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VRDN (100). This means that MRSN’s stock grew similarly to VRDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRSNVRDN
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
MRSN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MQIFX15.210.03
+0.20%
Franklin Mutual Quest Z
FCLKX16.020.02
+0.13%
Fidelity Large Cap Stock K6
KSDIX19.18-0.03
-0.16%
Keeley Small Cap Dividend Value I
MINRX34.80-0.08
-0.23%
MFS International Intrinsic Value R1
FNGDX15.59-0.05
-0.32%
Franklin Intl Growth C

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with VRDN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
N/A
VRDN - MRSN
41%
Loosely correlated
-2.22%
CRNX - MRSN
40%
Loosely correlated
+1.63%
RPTX - MRSN
39%
Loosely correlated
-1.39%
AVIR - MRSN
38%
Loosely correlated
+0.64%
AVTX - MRSN
38%
Loosely correlated
-1.36%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with ALLO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-2.22%
ALLO - VRDN
50%
Loosely correlated
-3.30%
FATE - VRDN
48%
Loosely correlated
+1.83%
AURA - VRDN
47%
Loosely correlated
-1.91%
CRBU - VRDN
47%
Loosely correlated
-1.51%
ABCL - VRDN
46%
Loosely correlated
-1.48%
More